The significance of postoperative follow-up of patients with advanced colorectal cancer using circulating tumor DNA—Selected case studies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26475821%3A_____%2F16%3AN0000014" target="_blank" >RIV/26475821:_____/16:N0000014 - isvavai.cz</a>
Result on the web
<a href="http://cancerres.aacrjournals.org/content/77/3_Supplement/B24" target="_blank" >http://cancerres.aacrjournals.org/content/77/3_Supplement/B24</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
The significance of postoperative follow-up of patients with advanced colorectal cancer using circulating tumor DNA—Selected case studies
Original language description
Poster at AACR Special Conference: Colorectal Cancer: From Initiation to Outcomes; September 17-20, 2016; Tampa, FL. The significance of postoperative follow up of patients with advanced colorectal cancer using circulating tumor DNA. One of the main possible uses of detection of circulating tumor DNA (ctDNA) in peripheral blood of patients with advanced colorectal cancer (CRC) is their long-term postoperative follow-up. With minimal invasiveness of tests may be performed at regular short intervals, without significant distress of the patient while monitoring the actual presence and volume of the tumor tissue (tumor burden) in the body of the patient. This is of particular importance when evaluating the radicality of surgery, monitoring the response to treatment, and for the early detection of disease recurrence. In this presentation we show the clinical application of ctDNA detection within the postoperative follow-up on five case metastatic CRC patients.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NV15-27939A" target="_blank" >NV15-27939A: Benefit of new "liquid biopsy" technology for monitoring of complex treatment of colorectal carcinoma in stage 3 and 4.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů